Pharvaris Statistics
Total Valuation
Pharvaris has a market cap or net worth of $2.38 billion. The enterprise value is $2.09 billion.
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharvaris has 69.88 million shares outstanding. The number of shares has increased by 14.13% in one year.
| Current Share Class | 69.88M |
| Shares Outstanding | 69.88M |
| Shares Change (YoY) | +14.13% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 3.03% |
| Owned by Institutions (%) | 54.58% |
| Float | 42.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 1,284.65 |
| PB Ratio | 8.17 |
| P/TBV Ratio | 8.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.24, with a Debt / Equity ratio of 0.00.
| Current Ratio | 11.24 |
| Quick Ratio | 10.99 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -994.49 |
Financial Efficiency
Return on equity (ROE) is -73.02% and return on invested capital (ROIC) is -46.40%.
| Return on Equity (ROE) | -73.02% |
| Return on Assets (ROA) | -42.31% |
| Return on Invested Capital (ROIC) | -46.40% |
| Return on Capital Employed (ROCE) | -72.58% |
| Weighted Average Cost of Capital (WACC) | -8.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 134 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharvaris has paid $2.26 million in taxes.
| Income Tax | 2.26M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.68% in the last 52 weeks. The beta is -2.33, so Pharvaris's price volatility has been lower than the market average.
| Beta (5Y) | -2.33 |
| 52-Week Price Change | +93.68% |
| 50-Day Moving Average | 30.50 |
| 200-Day Moving Average | 26.70 |
| Relative Strength Index (RSI) | 65.24 |
| Average Volume (20 Days) | 365,824 |
Short Selling Information
The latest short interest is 708,630, so 1.01% of the outstanding shares have been sold short.
| Short Interest | 708,630 |
| Short Previous Month | 600,645 |
| Short % of Shares Out | 1.01% |
| Short % of Float | 1.65% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -198.21M |
| Pretax Income | -192.09M |
| Net Income | -194.35M |
| EBITDA | -198.06M |
| EBIT | -198.21M |
| Earnings Per Share (EPS) | -$3.14 |
Full Income Statement Balance Sheet
The company has $284.74 million in cash and $851,944 in debt, giving a net cash position of $283.89 million or $4.06 per share.
| Cash & Cash Equivalents | 284.74M |
| Total Debt | 851,944 |
| Net Cash | 283.89M |
| Net Cash Per Share | $4.06 |
| Equity (Book Value) | 272.49M |
| Book Value Per Share | 4.17 |
| Working Capital | 270.68M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$169.92 million and capital expenditures -$64,237, giving a free cash flow of -$167.95 million.
| Operating Cash Flow | -169.92M |
| Capital Expenditures | -64,237 |
| Depreciation & Amortization | 154,041 |
| Net Borrowing | -200,492 |
| Free Cash Flow | -167.95M |
| FCF Per Share | -$2.40 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |